Drills Up, Prices Down: Medco Powering Through a Commodity Slump to Record Production

JAKARTA, Investortrust.id — For MedcoEnergi, Indonesia’s largest independent oil-and-gas player, 2025 was a year of running faster just to stay in place. The integrated energy giant, trading under the ticker MEDC, reported audited 2025 financial results on Thursday that showcased a paradox: surging physical production alongside a cooling bottom line.

While the company hit its operational marks, net profit for 2025 settled at $101 million, a sharp retreat from the $367 million recorded in 2024. The decline was fueled by a "perfect storm" of external pressures, including a 15 percent slide in benchmark oil prices—which fell from an average of $78 to $67 per barrel—and a diminished contribution from its copper-and-gold associate, Amman Mineral Internasional.

The strategic significance of Medco’s current trajectory lies in its transition from a pure-play hydrocarbon explorer into a regional energy conglomerate. By aggressively expanding its footprint in the Corridor PSC (Production Sharing Contract) and pivoting 25 percent of its power sales to renewables, Medco is attempting to "future-proof" its balance sheet against the very commodity volatility that eroded its 2025 earnings. For global investors, Medco serves as a bellwether for the Southeast Asian energy transition; its ability to maintain a Ba3 credit rating and secure an AAA ESG score from MSCI suggests that the company is successfully navigating the tightening capital markets for fossil fuel producers.

Navigating Impairments and Dry Holes

The profit squeeze wasn't solely due to market prices. CEO Roberto Lorato noted on Thursday that the 2025 figures were impacted by several non-cash and non-operational factors, including asset impairments and "dry hole" drilling costs at the Beluga PSC.

Despite these headwinds, EBITDA remained resilient at $1.264 billion, virtually unchanged from the previous year. "In 2025, we delivered a strong performance for the company and shareholders," Lorato said. He highlighted that the company returned $110 million to shareholders through dividends and buybacks, underpinned by a production cost of just $8.6 per barrel of oil equivalent (boe).

Operational Growth and 2026 Targets

On the ground, Medco’s pumps are working harder than ever. Production grew to 156 mboepd in 2025, catalyzed by the first oil from the Terubuk and Forel fields in the South Natuna Sea and a robust performance from its Block 60 operations in Oman.

The company also deepened its roots in Indonesia’s gas infrastructure, increasing its stake in the Corridor Block to 70 percent and acquiring a 45 percent interest in the Sakakemang PSC.

Looking ahead to 2026, President Director Hilmi Panigoro expressed high-octane optimism. "I am very satisfied with the 2025 performance," Hilmi said on April 2, 2026. "Entering 2026, we remain committed to providing added value, with a target for oil and gas production and electricity sales to once again set new records for Medco." The 2026 production target is set between 165 and 170 mboepd.

The Power and Mining Hedge

Medco’s power division sold 4,371 GWh in 2025, with a quarter of that coming from renewable sources. Capital expenditure of $35 million in this segment was funneled into the Ijen Geothermal project and the East Bali Solar PV plant.

Meanwhile, the company’s exposure to the mining sector through Amman Mineral continues to provide a massive, albeit volatile, upside. In 2025, the mining arm produced 208.9 million pounds of copper and 102.8 thousand ounces of gold. As the global shift toward electrification drives copper demand, Medco’s integrated model provides a unique hedge against the long-term decline of traditional oil demand.